MTOR and hepatocellular carcinoma: Differently from prostate cancer, mechanistic target of rapamycin (mTOR) protein, a key member of the PI3K-AKT-mTOR signaling pathway frequently hyperactivated in several malignancies, stimulates AR transcriptional activity in HCC.